Congenital heart disease (CHD) is the commonest birth defect, affecting just under 1% of the population – at least 700,000 people in the UK. Work we have done in UK general practice patients, using information predating mass COVID vaccination, has… Read more

Aortic stenosis (AS), or narrowing of the aortic valve, is the commonest reason for having heart valve surgery in the west, that causes poor quality of life and death, if untreated. It affects ~1-in-20 adults aged >65, but the exact… Read more

The benefits of Covid-19 vaccinations are well-known; they reduce the risk of infection and lower the risk of serious illness or death associated with Covid-19. Evidence in England and Scotland suggests rates of COVID-19 hospitalisation and COVID-19 death are around… Read more

Diabetes is a condition affecting approximately 4 million people in the UK. People with diabetes have high levels of blood glucose, which if unmanaged, can lead to serious damage to the heart, feet, eyes and kidneys. Previous research has shown… Read more

This research project is awarded through a funding call by Health Data Research UK and the Alan Turing Institute as part of the wider Data and Connectivity National Core Study. Further details on this project are available here. Read more

This project was funded through a rapid funding call by Health Data Research UK, Office for National Statistics and UK Research and Innovation (UKRI) as part of the wider Data and Connectivity National Core Study. Further details on this project… Read more

Antithrombotics are blood thinning medications that are used to treat a range of cardiovascular diseases. Atrial fibrillation (AF) is one such disease, and is the most common disturbance of heart rhythm and a common cause of stroke. In individuals who… Read more

Although cardiovascular disease (CVD), including heart attacks and strokes, is still the leading cause of death in the UK, the risk of CVD events and death can be reduced by identifying and treating major risk factors such as high blood… Read more